Angiotensin converting enzyme inhibitor potentiates the hypoglycaemic effect of NG-nitro-L-arginine methyl ester (L-NAME) in rats

References

• Aluko, E.O., et al., 2018. Reduction in nitric oxide bioavailability shifts serum lipid content towards atherogenic lipoprotein in rats. Biomedicine and pharmacotherapy, 101, 792–797.
   PubMed Web of Science ®Google Scholar
• Andreozzi, F., et al., 2004. Angiotensin II impairs the insulin signaling pathway promoting production of nitric oxide by inducing phosphorylation of insulin receptor substrate-1 on Ser312 and Ser616 in human umbilical vein endothelial cells. Circulation research, 94 (9), 1211–1218.
   PubMed Web of Science ®Google Scholar
• Åkesson, B., and Lundquist, I., 1999. Influence of nitric oxide modulators on cholinergically stimulated hormone release from mouse islets. The journal of physiology, 515 (2), 463–473.
   PubMed Web of Science ®Google Scholar
• Arnal, J.F., Warin, L., and Michel, J.B., 1992. Determinants of aortic cyclic guanosine monophosphate in hypertension induced by chronic inhibition of nitric oxide synthase. The journal of clinical investigation, 90 (2), 647–652.
   PubMed Web of Science ®Google Scholar
• Aykan, D.A., et al., 2020. Blockade of the neprilysin and angiotensin ameliorates oxidative stress in the cardiovascular target tissues of dexamethasone-induced hypertensive rats. Medical bulletin of Haseki, 58 (1), 1–8.
   Google Scholar
• Balon, T.W., and Nadler, J.L., 1997. Evidence that nitric oxide increases glucose transport in skeletal muscle. Journal of applied physiology (Bethesda, MD: 1985), 82 (1), 359–363.
   PubMed Web of Science ®Google Scholar
• Bernátová, I., Pechánová, O.G., and Simko, F., 1999. Effect of captopril in L-NAME-induced hypertension on the rat myocardium, aorta, brain and kidney. Experimental physiology, 84 (6), 1095–1105.
   PubMed Web of Science ®Google Scholar
• Boeing, T., et al., 2017. Diuretic and natriuretic effect of luteolin in normotensive and hypertensive rats: role of muscarinic acetylcholine receptors. Pharmacological reports: Pr, 69 (6), 1121–1124.
   PubMed Web of Science ®Google Scholar
• Bradley, S.J., Kingwell, B.A., and McConell, G.K., 1999. Nitric oxide synthase inhibition reduces leg glucose uptake but not blood flow during dynamic exercise in humans. Diabetes, 48 (9), 1815–1821.
   PubMed Web of Science ®Google Scholar
• Brandes, R.P., 2014. Endothelial dysfunction and hypertension. Hypertension (Dallas, Tex.: 1979), 64 (5), 924–928.
   PubMed Web of Science ®Google Scholar
• Broniowska, K.A., Oleson, B.J., and Corbett, J.A., 2014. β-Cell responses to nitric oxide. In: G. Litwack, ed. Vitamins and hormones. Vol. 95. USA: Academic Press, 299–322.
   Google Scholar
• Bryan, S., et al., 2011. The effect of nitric oxide inhibitors and Snitroso-Nacetylpenicillamine on glucose concentration in an animal model. Journal of natural science, biology and medicine, 2 (1), 80–86.
   PubMedGoogle Scholar
• Chua, B.H., et al., 1993. Regulation of endothelin-1 mRNA by angiotensin II in rat heart endothelial cells. Biochimica et biophysica acta (BBA) – molecular cell research, 1178 (2), 201–206.
   PubMedGoogle Scholar
• Cialdai, C., et al., 2010. Differences between zofenopril and ramipril, two ACE inhibitors, on cough induced by citric acid in guinea pigs: role of bradykinin and PGE2. Naunyn-Schmiedeberg's archives of pharmacology, 382 (5–6), 455–461.
   PubMed Web of Science ®Google Scholar
• Dabiré, H., et al., 2012. Vascular endothelial dysfunction in Duchenne muscular dystrophy is restored by bradykinin through upregulation of eNOS and nNOS. Basic research in cardiology, 107 (1), 240.
   PubMed Web of Science ®Google Scholar
• Deshpande, S.R., et al., 2012. Nitric oxide modulators: an emerging class of medicinal agents. Indian Journal of pharmaceutical science, 74 (6), 487–497.
   PubMed Web of Science ®Google Scholar
• Dharmashankar, K., and Widlansky, M.E., 2010. Vascular endothelialfunction and hypertension: insights and directions. Current hypertension reports, 12 (6), 445–448.
   Web of Science ®Google Scholar
• Durham, W.J., et al., 2003. Exogenous nitric oxide increases basal leg glucose uptake in humans. Metabolism, 52 (6), 662–665.
   PubMed Web of Science ®Google Scholar
• Govindarajan, G., Sowers, J.R., and Stump, C.S., 2006. Hypertension and diabetes mellitus. European cardiovascular disease, 2, 1–7.
   Google Scholar
• Hegyi, P., and Rakonczay, Jr., Z., 2011. The role of nitric oxide in the physiology and pathophysiology of the exocrine pancreas. Antioxidants and redox signaling, 15 (10), 2723–2741.
   PubMed Web of Science ®Google Scholar
• Heinonen, I., et al., 2013. Effect of nitric oxide synthase inhibition on the exchange of glucose and fatty acids in human skeletal muscle. Nutrition and metabolism, 10 (1), 43.
   Google Scholar
• Herman, L., and Bhimji, S., 2017. Angiotensin converting enzyme inhibitors (ACEI) [Updated 2017 Mar 24]. In: K. Bashir, ed. Stat pearls. Treasure Island (FL): Stat Pearls Publishing.
   Google Scholar
• Higaki, Y., et al., 2001. Nitric oxide increases glucose uptake through a mechanism that is distinct from the insulin and contraction pathways in rat skeletal muscle. Diabetes, 50 (2), 241–247.
   PubMed Web of Science ®Google Scholar
• Huang, Z., Jansson, L., and Sjöholm, Å., 2006. Pancreatic islet blood flow is selectively enhanced by captopril, irbesartan and pravastatin, and suppressed by palmitate. Biochemical and biophysical research communications, 346 (1), 26–32.
   PubMed Web of Science ®Google Scholar
• Inyard, A.C., et al., 2007. Contraction stimulates nitric oxide independent microvascular recruitment and increases muscle insulin uptake. Diabetes, 56 (9), 2194–2200.
   PubMed Web of Science ®Google Scholar
• Jellinger, P.S., et al., 2012. American Association of Clinical Endocrinologists’ guidelines for management of dyslipidemia and prevention of atherosclerosis. Endocrine practice, 18 (Supplement 1), 1–78.
   PubMedGoogle Scholar
• Jones, P.M., et al., 1992. Nitric oxide is not involved in the initiation of insulin secretion from rat islets of Langerhans. Diabetologia, 35 (11), 1020–1027.
   PubMed Web of Science ®Google Scholar
• Joost, H.G., and Tschop, M.H., 2007. No to obesity: does nitric oxide regulate fat oxidation and insulin sensitivity? Endocrinology, 148 (10), 4545–4547.
   PubMed Web of Science ®Google Scholar
• Jung, H.J., et al., 2010. Endogenous agmatine inhibits cerebral vascular matrix metalloproteinases expression by regulating activating transcription factor 3 and endothelial nitric oxide synthesis. Current neurovascular research, 7 (3), 201–212.
   PubMed Web of Science ®Google Scholar
• Kampf, C., et al., 2005. Angiotensin II type 1 receptor inhibition markedly improves the blood perfusion, oxygen tension and first phase of glucose-stimulated insulin secretion in revascularised syngeneic mouse islet grafts. Diabetologia, 48 (6), 1159–1167.
   PubMed Web of Science ®Google Scholar
• Kingwell, B.A., et al., 2002. Nitric oxide synthase inhibition reduces glucose uptake during exercise in individuals with type 2 diabetes more than in control subjects. Diabetes, 51 (8), 2572–2580.
   PubMed Web of Science ®Google Scholar
• Linz, W., et al., 1995., Angiotensin converting enzyme inhibitors, left ventricular hypertrophy and fibrosis. In Cellular interactions in cardiac pathophysiology. Boston, MA: Springer, 89–97.
   Google Scholar
• Luis, S.L.O., Scott, R., and Joern, R.S., 2016. Nitric oxide: a regulator of cellular function in health and disease. Oxidative medicine and cellular longevity, 2016, 9782346.
   PubMed Web of Science ®Google Scholar
• Majed, B.H., and Khalil, R.A., 2012. Molecular mechanisms regulating the vascular prostacyclin pathways and their adaptation during pregnancy and in the newborn. Pharmacological reviews, 64 (3), 540–582.
   PubMed Web of Science ®Google Scholar
• Marty, K.S.W., 2016. Handbook of hormones. Comparative endocrinology for basic and clinical research. 1st ed. Japan: Academic press, 253–254.
   Google Scholar
• Mingorance, C., Andriantsitohaina, R., and de Sotomayor, M.A., 2008. Cedrelopsis grevei improves endothelial vasodilatation in aged rats through an increase of no participation. Journal of ethnopharmacology, 117 (1), 76–83.
   PubMed Web of Science ®Google Scholar
• Moinuddin, G., et al., 2011. Modulation of hemodynamics, endogenous antioxidant enzymes, and pathophysiological changes by angiotensin-converting enzyme inhibitors in pressure-overload rats. Hellenike Kardiologike Epitheorese [Hellenic journal of cardiology: HJC], 52 (3), 216–226.
   PubMed Web of Science ®Google Scholar
• Mombouli, J.V., et al., 1992. Potentiation of endothelium-dependent relaxations to bradykinin by angiotensin I converting enzyme inhibitors in canine coronary artery involves both endothelium-derived relaxing and hyperpolarizing factors. Circulation research, 71 (1), 137–144.
   PubMed Web of Science ®Google Scholar
• Mombouli, J.V., and Vanhoutte, P.M., 1995. Endothelium-derived hyperpolarizing factor(s) and the potentiation of kinins by converting enzyme inhibitors. American journal of hypertension, 8 (5 Pt 2), 19S–27S.
   PubMed Web of Science ®Google Scholar
• Mosaad, S.M., et al., 2017. Celecoxib aggravates cardiac apoptosis in L-NAME-induced pressure overload model in rats: immunohistochemical determination of cardiac caspase-3, Mcl-1, Bax and Bcl-2. Chemico-biological interactions, 272, 92–106.
   PubMed Web of Science ®Google Scholar
• Nikhil, O., et al., 2012. Nitric oxide: role in human biology. International journal of pharmaceutical sciences and drug research, 4 (2), 105–109.
   Google Scholar
• Nyadjeu, P., et al., 2013. Acute and chronic antihypertensive effects of Cinnamomum zeylanicum stem bark methanol extract in L-NAME-induced hypertensive rats. BMC complementary and alternative medicine, 13 (1), 27.
   PubMedGoogle Scholar
• Ozden, H., et al., 2009. The protective effect of NG-nitro-L-arginine methyl ester and insulin on nitric oxide inhibition and pathology in experimental diabetic rat liver. Saudi medical journal, 30 (1), 30–34.
   PubMed Web of Science ®Google Scholar
• Peng, X., et al., 2019. Ramipril and resveratrol co‐treatment attenuates RhoA/ROCK pathway‐regulated early‐stage diabetic nephropathy‐associated glomerulosclerosis in streptozotocin‐induced diabetic rats. Environmental toxicology, 34 (7), 861–868.
   PubMed Web of Science ®Google Scholar
• Pollare, T., Lithell, H., and Berne, C., 1989. A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. New England journal of medicine, 321 (13), 868–873.
   PubMed Web of Science ®Google Scholar
• Rizos, C.V., and Elisaf, M.S., 2014. Antihypertensive drugs and glucose metabolism. World journal of cardiology, 6 (7), 517–530.
   PubMedGoogle Scholar
• Rodriguez-Gomez, I., et al., 2003. Effects of omapatrilat on blood pressure and renal injury in L-NAME and L-NAME plus DOCA-treated rats. American journal of hypertension, 16 (1), 33–38.
   PubMed Web of Science ®Google Scholar
• Salami, S.A., et al., 2017. Oral administration of Tridax procumbens aqueous leaf extract attenuates reproductive function impairments in L-NAME induced hypertensive male rats. Middle East fertility society journal, 22 (3), 219–225.
   Web of Science ®Google Scholar
• Schmidt, H.X.H., et al., 1992. Insulin secretion from pancreatic B cells caused by L-arginine-derived nitrogen oxides. Science (New York, N.Y.), 255 (5045), 721–723.
   PubMed Web of Science ®Google Scholar
• Sen, S., et al., 2014. Renin inhibitors in diabetes and hypertension: an update. EXCLI Journal, 13, 1111–1119.
   PubMed Web of Science ®Google Scholar
• Seth, M.K., et al., 2016. Effects of a novel ACE inhibitor, 3-(3-thienyl)-l-alanyl-ornithyl-proline, on endothelial vasodilation and hepatotoxicity in l-NAME-induced hypertensive rats. Drug design, development and therapy, 10, 1533–1542.
   PubMed Web of Science ®Google Scholar
• Solski, L.V., and Longyhore, D.S., 2008. Prevention of type 2 diabetes mellitus with angiotensin-converting-enzyme inhibitors. American journal of health-system pharmacy: AJHP: Official journal of the American Society of Health-System Pharmacists, 65 (10), 935–940.
   PubMed Web of Science ®Google Scholar
• Spinas, G.A., 1999. The dual role of nitric oxide in islet beta-cells. News in physiological sciences: an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society, 14, 49–54.
   PubMedGoogle Scholar
• Spinas, G.A., et al., 1998. The early phase of glucose-stimulated insulin secretion requires nitric oxide. Diabetologia, 41 (3), 292–299.
   PubMed Web of Science ®Google Scholar
• Suzuki, K., Nakagawa, O., and Aizawa, Y., 2008. Improved early-phase insulin response after candesartan treatment in hypertensive patients with impaired glucose tolerance. Clinical and experimental hypertension (New York, N.Y.: 1993), 30 (5), 309–314.
   PubMed Web of Science ®Google Scholar
• Takamura, T., et al., 1998. Transgenic mice overexpressing type 2 nitric-oxide synthase in pancreatic beta cells develop insulin-dependent diabetes without insulitis. The journal of biological chemistry, 273 (5), 2493–2496.
   PubMed Web of Science ®Google Scholar
• Tsimihodimos, V., et al., 2018. Hypertension and diabetes mellitus: coprediction and time trajectories. Hypertension (Dallas, Tex.: 1979), 71 (3), 422–428.
   PubMed Web of Science ®Google Scholar
• Weigert, N., et al., 1992. Contribution of neural intrapancreatic non-cholinergic non-adrenergic mechanisms to glucose-induced insulin release in the isolated rat pancreas. Diabetologia, 35 (12), 1133–1139.
   PubMed Web of Science ®Google Scholar
• Yusuf, S., HOPE Study Investigators., et al., 2001. Ramipril and the development of diabetes. JAMA, 286 (15), 1882–1885.
   PubMed Web of Science ®Google Scholar
• Zicha, J., Dobesová, Z., and Kunes, J., 2006. Antihypertensive mechanisms of chronic captopril or N-acetylcysteine treatment in L-NAME hypertensive rats. Hypertension research, 29 (12), 1021–1027.
   PubMed Web of Science ®Google Scholar